Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Stretch Mark Cream

Louisiana House Approves Bill Allowing Providers To Refuse Certain Reproductive Health Services
The Louisiana House on Tuesday voted 82-13 to approve legislation (HB 517) that would allow some health professionals to refuse to provide certain medical services that they object to on religious or moral grounds, the New Orleans Times-Picayune reports.The House-passed bill is an amended version of a measure, introduced by Rep. Bernard LeBas (D), that a House committee rejected earlier this month. The revised bill narrowed the list of procedures that can be denied, and it applies to health providers only in public facilities, not religious health facilities statewide as in the original bill. Under the bill, public health care employees would be allowed to decline to provide abortions or abortifacient drugs. They also would be allowed to refuse participation in embryonic stem cell research or cloning, euthanasia and physician-assisted suicide. Public employees would be immune from civil lawsuits and have job security under the measure.According to the Times-Picayune, Gov. Bobby Jindal"s (R) administration backed the original bill in committee, although state Health Secretary Alan Levine indicated that the bill"s original provisions were too broad. Under the original measure, health care providers would have been allowed to refuse services such as artificial insemination, sterilization, artificial reproductive technologies and "dispensation of drugs affecting the reproductive process." The original measure also would have covered both public and private health care providers (Barrow, New Orleans Times-Picayune, 5/20).Prior to passage, the House approved an amendment to narrow the scope of the bill offered by Rep. John Bel Edwards (D), who said that the original bill"s provisions were not specific enough and could pose problems for private businesses. He also said that the original bill would have posed barriers to patients seeking access to basic treatments and medications (AP/New Orleans Times-Picayune, 5/19). The measure now advances to the state Senate for debate (New Orleans Times-Picayune, 5/20).
generic viagra online
AdvanDx Receives FDA 510(k) Clearance For GBS PNA FISH(R) For Rapid Detection Of Group B Strep From Lim Broths
AdvanDx announced it received FDA 510(k) clearance for GBS PNA FISH® for detection of Streptococcus agalactiae, aka Group B Strep, from turbid Lim Broths inoculated with vaginal and rectal swabs obtained from pregnant women between 35 and 37 weeks gestation. The 90 minute molecular diagnostic test enables rapid and highly sensitive detection of Group B Strep from Lim Broths to help detect colonization in pregnant women. Purchase zoloft to treat depression.
News of the day
Sen. Sessions To Give Floor Speeches On Judiciary As GOP Prepares For Sotomayor Debate
Sen. Jeff Sessions (R-Ala.), the ranking member on the Senate Judiciary Committee, on Wednesday is expected to outline the Republican Party"s vision for the judiciary and the kinds of judges the GOP supports for the Supreme Court in the first of a series of floor speeches, according to committee s, Roll Call reports. Although the speeches are not directly targeted at Supreme Court nominee Judge Sonia Sotomayor, Sessions said he hopes they will begin a "national dialogue" on the judiciary"s role ahead of her confirmation hearing, which is scheduled to begin July 13. Sessions is expected to give four to five speeches, which also will appear as opinion pieces in the Washington Times this week. His first speech will address his views on the foundation of a strong judiciary and judicial restraint. The later speeches will focus on President Obama"s call for judges who display "empathy" and other issues, according to Roll Call. The committee said the speeches "will address the fundamental issues that will be in play during the confirmation process" and "make the case for judicial restraint versus judicial activism."According to Roll Call, part of Sessions" motivation for giving the speeches is to clarify the definition of terms like "judicial restraint," "activist judge" and "empathy standard," phrases that frequently arise in debates over judges but might not be widely understood among judicial outsiders and the general public. Senators are expected to question Sotomayor on such topics during her confirmation hearing, and Sessions aims to define the context of the terms before the hearings begin, Roll Call reports. Senate Judiciary Committee Chair Patrick Leahy (D-Vt.) said that he is optimistic that Sotomayor"s hearings will remain bipartisan and that Republicans would not attempt to derail them by boycotting the hearings. He added that he believes GOP senators will participate in the hearings despite their complaints that they have not had enough time to prepare (Stanton, Roll Call, 6/17).
Health Insurance

Link Between Breast Cancer Hormone Receptor Status And Risk Of A Second Primary Tumor

Women with hormone receptor (HR) negative first tumors have twice as much risk for developing a second breast cancer as women with HR-positive tumors, according to a study published online July 9 in the Journal of the National Cancer Institute. Christina A. Clarke, Ph.D., of the Northern California Cancer Center in Fremont, Calif., and colleagues examined data from the National Cancer Institute"s Surveillance, Epidemiology, and End Results database to analyze whether a first tumor"s estrogen receptor and progesterone receptor content and the age or race of the woman has anything to do with her risk of a second tumor. They found that women who have had breast cancer are at increased risk of a second primary breast cancer, compared with risk in the general population. They also found that women whose first tumors were hormone-receptor negative, compared with those whose tumors were hormone-receptor positive, had almost twice as much risk of any second breast cancer, and a five-fold increase in risk of a second hormone-receptor negative breast cancer. "Future research should focus on identifying genetic factors that predispose women to multiple HR-negative tumors to target screening, prevention, and treatment strategies more effectively," the author writes. Steve Graff Journal of the National Cancer Institute


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009